Wu Guo-Lan, Zhou Hui-Li, Shentu Jian-Zhong, He Qiao-Jun, Yang Bo
Institute of Pharmacology & Toxicology and Biochemical Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
J Pharm Biomed Anal. 2008 Dec 15;48(5):1485-9. doi: 10.1016/j.jpba.2008.09.046. Epub 2008 Oct 8.
A simple, sensitive and rapid LC/MS/MS method was developed for the quantification of lansoprazole in human plasma. After a simple sample preparation procedure by one-step protein precipitation with acetonitrile, lansoprazole and the internal standard bicalutamide were chromatographed on a Zorbax SB-C(18) (3.0 mm x 150 mm, 3.5 microm, Agilent) column with the mobile phase consisted of methanol-water (70:30, v/v, containing 5 mM ammonium formate, pH was adjusted to 7.85 by 1% ammonia solution). Detection was performed on a triple quadrupole tandem mass spectrometry by multiple reaction monitoring (MRM) mode via negative eletrospray ionization source (ESI(-)). The lower limit of quantification was 5.5 ng/mL, and the assay exhibited a linear range of 5.5-2200.0 ng/mL. The validated method was successfully applied to investigate the bioequivalence between two kinds of preparation (test vs. reference product) in twenty-eight healthy male Chinese volunteers.
建立了一种简单、灵敏、快速的液相色谱-串联质谱法(LC/MS/MS)用于定量测定人血浆中的兰索拉唑。通过用乙腈一步沉淀蛋白进行简单的样品制备后,兰索拉唑和内标比卡鲁胺在Zorbax SB-C(18)(3.0 mm×150 mm,3.5 µm,安捷伦)柱上进行色谱分离,流动相为甲醇-水(70:30,v/v,含5 mM甲酸铵,用1%氨溶液将pH调至7.85)。采用三重四极杆串联质谱,通过负离子电喷雾电离源(ESI(-))的多反应监测(MRM)模式进行检测。定量下限为5.5 ng/mL,该方法的线性范围为5.5 - 2200.0 ng/mL。该验证方法成功应用于28名中国健康男性志愿者,以研究两种制剂(受试制剂与参比制剂)之间的生物等效性。